Chih Hung Yeh
Directeur Général chez TAIWAN LIPOSOME COMPANY, LTD.
Profil
Chih Hung Yeh is currently the General Manager & Director at Taiwan Liposome Co., Ltd., the Director at TLC Biopharmaceuticals HK Ltd., the Managing Director at TLC Biopharmaceuticals B.V., the General Manager & Director at TLC Biopharmaceuticals Shanghai Ltd., the Director at TLC Biopharmaceuticals Pty Ltd., the President & Director at TLC Biopharmaceuticals Japan Co., Ltd., the Director at Steminent Biotherapeutics, Inc., the Director at Woods Investment Co. Ltd., and the General Manager at TLC Biopharmaceuticals, Inc. .
Mr. Yeh previously worked as an Associate at General Bank, the Chief Financial Officer at Hermes Biosciences, Inc., and the Vice President at Asiawired Group.
Mr. Yeh received an undergraduate degree from the University of California, Berkeley, and graduate degrees including an MBA from the University of Michigan.
Postes actifs de Chih Hung Yeh
Sociétés | Poste | Début |
---|---|---|
TAIWAN LIPOSOME COMPANY, LTD. | Directeur Général | - |
STEMINENT BIOTHERAPEUTICS, INC | Directeur/Membre du Conseil | 08/12/2021 |
TLC Biopharmaceuticals, Inc. | Corporate Officer/Principal | - |
TLC Biopharmaceuticals HK Ltd. | Directeur/Membre du Conseil | - |
TLC Biopharmaceuticals B.V. | Directeur Général | - |
TLC Biopharmaceuticals Shanghai Ltd. | Directeur Général | - |
TLC Biopharmaceuticals Pty Ltd. | Directeur/Membre du Conseil | - |
TLC Biopharmaceuticals Japan Co., Ltd. | President | - |
Woods Investment Co. Ltd.
Woods Investment Co. Ltd. Financial ConglomeratesFinance Woods Investment Co. Ltd. provides investment services. The private company is based in Taipei, TW. and has a global presence of subsidiaries in several regions. Woods Investment Co. was founded in 2021. | Directeur/Membre du Conseil | - |
Anciens postes connus de Chih Hung Yeh
Sociétés | Poste | Fin |
---|---|---|
░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Chih Hung Yeh
University of California, Berkeley | Undergraduate Degree |
University of Michigan | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
STEMINENT BIOTHERAPEUTICS, INC | Health Technology |
Entreprise privées | 11 |
---|---|
General Bank | Finance |
Taiwan Liposome Co., Ltd.
Taiwan Liposome Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiwan Liposome Co., Ltd. engages in the research and development of lipid-based formulation drugs. Its products are used for pain management, eye disease treatment, and cancer treatment. The company was founded by Kee Lung Hong on November 10, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
Hermes Biosciences, Inc.
Hermes Biosciences, Inc. BiotechnologyHealth Technology Hermes Biosciences, Inc. develops innovative targeted drug delivery technologies for therapeutic and other biomedical applications. The company was founded by John W. Park, James D. Marks, Keelung Hong and Christopher Benz and is headquartered in South San Francisco, CA. | Health Technology |
Asiawired Group | |
TLC Biopharmaceuticals, Inc. | |
TLC Biopharmaceuticals HK Ltd. | |
TLC Biopharmaceuticals B.V. | |
TLC Biopharmaceuticals Shanghai Ltd. | |
TLC Biopharmaceuticals Pty Ltd. | |
TLC Biopharmaceuticals Japan Co., Ltd. | |
Woods Investment Co. Ltd.
Woods Investment Co. Ltd. Financial ConglomeratesFinance Woods Investment Co. Ltd. provides investment services. The private company is based in Taipei, TW. and has a global presence of subsidiaries in several regions. Woods Investment Co. was founded in 2021. | Finance |